Zimvie INC DEF 14A proxy statements

ZimVie Inc. has provided frequently asked questions to employees regarding the proposed acquisition by an ARCHIMED affiliate, detailing voting procedures for shareholders.

ZimVie Inc. issues supplemental disclosures to its merger proxy amid stockholder lawsuits, reaffirms board's unanimous recommendation for Zamboni Parent acquisition.

ZimVie Inc. stockholders are invited to a special meeting on October 10, 2025, to vote on the proposed acquisition by ARCHIMED for $19.00 per share in cash.

ZimVie Inc. reported improved second-quarter 2025 financial results while confirming its definitive agreement to be acquired by ARCHIMED for $19.00 per share in cash.

ZimVie Inc. announced its second quarter 2025 financial results will be reported on July 30, 2025, while reiterating its definitive agreement to be acquired by an ARCHIMED affiliate for $19.00 in cash per share, with the transaction expected to close by year-end 2025.

ZimVie Inc. has entered into a definitive agreement to be acquired by Zamboni Parent, Inc., an affiliate of ARCHIMED, a private equity firm focused on healthcare industries.

ZimVie has announced a definitive agreement to be acquired by Zamboni Parent, Inc., an affiliate of ARCHIMED, a private equity firm specializing in healthcare industries.

ZimVie Inc. has entered into a definitive merger agreement to be acquired by an affiliate of ARCHIMED for $19.00 per share in cash, representing a significant premium for stockholders.

ZimVie Inc. announces its shareholder meeting to be held on May 7, 2025, with key items including the election of a director, ratification of the appointment of PricewaterhouseCoopers LLP, and approval of executive compensation.

ZimVie Inc. completes the sale of its Spine business, refocuses on dental, and announces leadership changes including Vafa Jamali assuming the role of Chair and Vinit Asar becoming Lead Independent Director.

ZimVie Inc. finalizes the sale of its Spine business to H.I.G. Capital for $375 million, pivoting to concentrate on its dental market operations.

ZimVie Inc. announces its 2024 Annual Meeting and encourages shareholders to review proxy materials and vote by May 14, 2024.

ZimVie Inc.'s proxy statement details proposals for the 2024 annual shareholder meeting, including director elections, auditor ratification, and executive compensation approval.